DIY Life Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Zazzle - Wikipedia

    en.wikipedia.org/wiki/Zazzle

    Zazzle. Zazzle is an American online marketplace that allows designers and customers to create their own products with independent manufacturers (clothing, posters, etc.), as well as use images from participating companies. Zazzle has partnered with many brands to amass a collection of digital images from companies like Disney, Warner Brothers ...

  3. New Jersey Motor Vehicle Commission - Wikipedia

    en.wikipedia.org/wiki/New_Jersey_Motor_Vehicle...

    State of New Jersey. Website. www .nj .gov /mvc. The New Jersey Motor Vehicle Commission ( NJMVC or simply MVC) is a governmental agency of the U.S. state of New Jersey. The equivalent of the Department of Motor Vehicles in other states, it is responsible for titling, registering and inspecting automobiles, and issuing driver's licenses .

  4. Multiview Video Coding - Wikipedia

    en.wikipedia.org/wiki/Multiview_Video_Coding

    Multiview Video Coding. Multiview Video Coding ( MVC, also known as MVC 3D) is a stereoscopic video coding standard for video compression that allows for encoding of video sequences captured simultaneously from multiple camera angles in a single video stream. [1]

  5. MVC COVID-19 vaccine - Wikipedia

    en.wikipedia.org/wiki/MVC_COVID-19_vaccine

    The MVC COVID-19 vaccine (Chinese: 高端新冠肺炎疫苗; pinyin: Gāoduān xīnguàn fèiyán yìmiáo; Wade–Giles: Kaotuan hsinkuan feiyen imiao), designated MVC-COV1901 and also known as the Medigen COVID-19 vaccine, is a protein subunit COVID-19 vaccine developed by Medigen Vaccine Biologics Corporation in Taiwan, American company ...

  6. Walvax COVID-19 vaccine - Wikipedia

    en.wikipedia.org/wiki/Walvax_COVID-19_vaccine

    COVID-19 pandemic. AWcorna, originally termed ARCoV [1] and also known as the Walvax COVID-19 vaccine, is an mRNA COVID-19 vaccine developed by Walvax Biotechnology, Suzhou Abogen Biosciences, and the PLA Academy of Military Science. [2] In contrast to other mRNA COVID vaccines, such as those by Pfizer-BioNtech and Moderna, this vaccine ...

  7. Sanofi–GSK COVID-19 vaccine - Wikipedia

    en.wikipedia.org/wiki/Sanofi–GSK_COVID-19_vaccine

    The Sanofi–GSK COVID‑19 vaccine is a recombinant protein subunit vaccine containing the SARS-CoV-2 spike protein, which is produced in insect cells via a baculovirus vector. It also includes an adjuvant made by GSK. It uses the same technology as Sanofi's Flublok influenza vaccine. [7] [8]

  8. COVI-VAC (U.S. COVID-19 vaccine) - Wikipedia

    en.wikipedia.org/wiki/COVI-VAC_(U.S._COVID-19...

    Medical uses The vaccine is administered intranasally and requires a single dose. Pharmacology COVI-VAC is a live attenuated vaccine. Clinical trials Phase I In December 2020, Codagenix started a Phase I trial in the United Kingdom. In September 2021, Codagenix reported that the trial had shown COVI-VAC to be safe and immunogenic. References ^ "Serum Institute starts manufacturing Codagenix's ...

  9. West China Hospital COVID-19 vaccine - Wikipedia

    en.wikipedia.org/wiki/West_China_Hospital_COVID...

    Clinical trials In August 2020, WestVac Biopharma started phase I clinical trials with 168 participants in China. In November, WestVac Biopharma started phase II clinical trials with 960 participants in China In February 2021, WestVac Biopharma started phase IIb clinical trials with 4,000 participants in China. Later, WestVac Biopharma is no longer on phase IIb clinical trial. In June 2021 ...

  10. COVAX-19 - Wikipedia

    en.wikipedia.org/wiki/COVAX-19

    Medical uses It requires two doses 21 days apart given by intramuscular injection. Pharmacology COVAX-19 is a recombinant protein subunit. History Vaxine began work on a COVID-19 vaccine in January 2020. After developing a vaccine adjuvant the company decided to focus on a "recombinant protein-based vaccine". A phase 1 human trial started in June 2020. The phase 1 trial involved 40 ...

  11. ARCT-154 - Wikipedia

    en.wikipedia.org/wiki/ARCT-154

    ARCT-154, also known as VBC-COV19-154 in Vietnam, is a COVID-19 vaccine candidate developed by Arcturus Therapeutics. [1] [2] For its development, Arcturus collaborated with Vinbiocare, a Vietnamese company, for support with clinical trials and manufacturing.